Study of GentleWave System shows ‘extremely high’ healing rates

Search Dental Tribune

Study of GentleWave System shows ‘extremely high’ healing rates

A study has been published in the Journal of Endodontics on 12-month healing rates using Sonendo’s GentleWave System as an alternative to standard root canal therapy. (Photo: Sonendo)
Dental Tribune USA

Dental Tribune USA

Tue. 15 November 2016


Sonendo Inc. — the Laguna Hills, Calif.-based developer of a breakthrough technology that offers an alternative to conventional root canal therapy — recently announced that clinical results using its GentleWave System were reported in the print and online issues of the Journal of Endodontics. The study can be found online, at

The work was led by Prof. Asgeir Sigurdsson, cand, Odont., DDS, MS, Cert End (UNC), chairman of endodontics at the University of New York College of Dentistry, who stated, “This study strongly indicates that the GentleWave System does what it was intended to do; it cleans and disinfects the root canal space in a predictable and consistent way resulting in periapical healing rates that are extremely high in this study. Most importantly, though, is the fact that the system does this automatically and with maximal preservation of tooth and root structure.”

Chris Rabbitt, chief commercial officer of Sonendo, stated, “We applaud the investigators in this study for their rigor in examining how the GentleWave System can offer expedited healing rates in root canal therapy through improved cleaning, disinfection and preservation of natural tooth morphology. We are compelled to reference this data as we move toward broader commercialization of the GentleWave System and ultimately deliver on our mission of ‘Saving Teeth Through Sound Science.’”

Bjarne Bergheim, president and CEO of Sonendo, also stated, “Sonendo is committed to improving care for patients. We are therefore excited about this study: The GentleWave System enables improved healing and a cumulative success rate of 97.3 percent.[1] Over the past century, little has changed in root canal therapy. We are pleased that the GentleWave System is finally giving clinicians and their patients a better alternative than conventional root canal therapy.”

Glenn named chief financial officer

In other news from Sonendo, John (Jack) Glenn was recently named chief financial officer. Glenn brings 25 years of financial leadership experience to his new position.

“I am thrilled to welcome Jack to the Sonendo team,” Bergheim said. “Jack’s leadership and public company experience will position Sonendo for exciting opportunities in the years ahead as we continue to pursue transformative technologies within the dental space.”

Before joining Sonendo, Glenn most recently served as chief financial officer of Armetheon Corp., a privately held, San Francisco Bay Area specialty biopharmaceutical company. Prior to this, he served as chief financial officer of publicly traded Solta Medical, where he played a key role in the identification, negotiation and structuring of several acquisitions, public equity offerings and debt financings and assisted in the company’s strategic acquisition by Valeant Pharmaceutical. Glenn earned his MBA in finance from Santa Clara University and his BS in business administration from the University of Nevada.

“Sonendo is at an exciting stage in the company’s pursuit of changing the standard of care for root canal therapy,” Glenn said. “I’m excited to join the Sonendo organization and help realize the value of this innovative technology.”

About Sonendo

Sonendo is a privately held, venture-backed company developing technologies that aim to transform dentistry by “Saving Teeth Through Sound Science.” The first commercially available product from Sonendo, the GentleWave System, available in the U.S., shows significant improvements in clinical efficacy and treatment efficiency when compared to conventional root canal techniques.[2-3] More information is available online, at

(Source: Sonendo. A complete list of references is available from the publisher.)

Leave a Reply

Your email address will not be published. Required fields are marked *